Question 1

What is BridgeBio Oncology Therapeutics, Inc. (BBOT)'s latest operating cash flow?

Accepted Answer

BridgeBio Oncology Therapeutics, Inc. (BBOT)'s operating cash flow for FY2025 was -$113.9M, as reported in its SEC filings.

Question 2

How has BridgeBio Oncology Therapeutics, Inc. (BBOT)'s operating cash flow changed year over year?

Accepted Answer

BBOT's operating cash flow went from -$55.0M in FY2024 to -$113.9M in FY2025, a decrease of 107.0%.

Question 3

What is the highest operating cash flow BridgeBio Oncology Therapeutics, Inc. (BBOT) reported over FY2024–FY2025?

Accepted Answer

The highest reported operating cash flow over FY2024–FY2025 was -$55.0M, in FY2024.

Question 4

What years does this operating cash flow history cover?

Accepted Answer

This page shows BBOT's operating cash flow for each fiscal year from FY2024 to FY2025, drawn from SEC XBRL filings.

Fiscal year	Value	YoY
FY2025	-$113.9M	-107.0%
FY2024	-$55.0M	—

BridgeBio Oncology Therapeutics, Inc. (BBOT) Operating cash flow 2024–2025

More BBOT financial trends